November 8, 2016
Read More
June 1, 2016
Read More
Preliminary Activity in the First in Human Study of the First-In-Class Fatty Acid Synthase (FASN) Inhibitor, TVB-2640 (Poster and Poster Discussion Sessions at the ASCO Meeting on Sunday June 5, 2016, Abstract #2512, Board #212)
April 19, 2016
Read More
FASN inhibitor TVB-2640 shows pharmacodynamic effect and evidence of clinical activity in KRAS-mutant NSCLC patients in a phase I study (Poster Presentation at AACR Meeting on Monday Apr 18, 2016 1:00 PM, Abstract number LB-214)
April 19, 2016
Read More
Preclinical studies characterize tumor type sensitivity to FASN inhibition and the mechanism and efficacy of novel drug combinations with TVB-2640 (Poster Presentation at AACR Meeting on Wednesday, April 20, 2016, Abstract number 4743)
March 24, 2016
Read More
Preliminary Activity in the First in Human Study of the First-In-Class Fatty Acid Synthase (FASN) Inhibitor, TVB-2640” presented by Dr. Manish Patel at the Targeted Anticancer Therapies (TAT) Congress on Wednesday March 23, 2016 at 12 noon EDT
March 2, 2016
Read More
Sebum Analysis from Dose Escalation and Expansion Phases of the FASN Inhibitor TVB-2640 Phase 1 Trial, A Non-Invasive Biomarker of Target Engagement (Abstract #1022 and Short Presentation at Keystone Symposium, “New Frontiers in Understanding Tumor Metabolism” February 21-25, 2016, Banff, Alberta, Canada)
November 8, 2015
Read More
FASN inhibition studies in preclinical tumor models identify biomarkers that align with in vitro and in vivo sensitivity to TVB-2640 (Poster Presentation at AACR-NCI-EORTC meeting on Sunday Nov 8, 2015)
November 7, 2015
Read More
Biomarker Analyses from Dose Escalation Phase of FASN Inhibitor TVB-2640 Phase 1 Study Shows Target Engagement in Solid Tumor Patients (Poster presented at AACR-NCI-EORTC Meeting on Saturday, Nov 7, 2015)
October 27, 2015
Read More
A First-In-Human Study of the First-In-Class Fatty Acid Synthase (FASN) Inhibitor TVB-2640 Results of Dose Escalation in Mono and Combination and Evidence of Preliminary Activity (Poster presentation at AACR-NCI-EORTC Meeting Session A on Friday Nov 6, 2015 12:15 PM – 3:15 PM)
October 12, 2015
Read More